Mutations in the gene SFTPC, encoding surfactant protein C (SP-C), are associated with interstitial lung disease in children and adults. To assess the natural history of disease, we knocked in a familial, disease-associated SFTPC mutation, L188Q (L184Q [LQ] in mice), into the mouse Sftpc locus. Translation of the mutant proprotein, proSP-CLQ, exceeded that of proSP-CWT in neonatal alveolar type 2 epithelial cells (AT2 cells) and was associated with transient activation of oxidative stress and apoptosis, leading to impaired expansion of AT2 cells during postnatal alveolarization. Differentiation of AT2 to AT1 cells was also inhibited in ex vivo organoid culture of AT2 cells isolated from LQ mice; importantly, treatment with antioxidant promoted alveolar differentiation. Upon completion of alveolarization, SftpcLQ expression was downregulated, leading to resolution of chronic stress responses; however, the failure to restore AT2 cell numbers resulted in a permanent loss of AT2 cells that was linked to decreased regenerative capacity in the adult lung. Collectively, these data support the hypothesis that susceptibility to disease in adult LQ mice is established during postnatal lung development, and they provide a potential explanation for the delayed onset of disease in patients with familial pulmonary fibrosis.
Sneha Sitaraman, Emily P. Martin, Cheng-Lun Na, Shuyang Zhao, Jenna Green, Hitesh Deshmukh, Anne-Karina T. Perl, James P. Bridges, Yan Xu, Timothy E. Weaver
Title and authors | Publication | Year |
---|---|---|
Exhaled breath condensate contains extracellular vesicles (EVs) that carry miRNA cargos of lung tissue origin that can be selectively purified and analyzed
Mitchell MI, Ben\u2010Dov IZ, Ye K, Liu C, Shi M, Sadoughi A, Shah C, Siddiqui T, Okorozo A, Gutierrez M, Unawane R, Biamonte L, Parihk K, Spivack S, Loudig O |
Journal of Extracellular Vesicles | 2024 |
Effects of Natural Products through Inhibiting Endoplasmic Reticulum Stress on Attenuation of Idiopathic Pulmonary Fibrosis
Deng J, Liu J, Chen W, Liang Q, He Y, Sun G |
Drug design, development and therapy | 2024 |
Humanized L184Q Mutated Surfactant Protein C Gene Alters Alveolar Type 2 Epithelial Cell Fate
Jain KG, Liu Y, Zhao R, Muire PJ, Zhang J, Zang QS, Ji HL |
International Journal of Molecular Sciences | 2024 |
Engraftment of wild-type alveolar type II epithelial cells in surfactant protein C deficient mice
Predella C, Lapsley L, Ni K, Murray JW, Liu HY, Motelow JE, Snoeck HW, Glasser SW, Saqi A, Dorrello NV |
Research Square | 2024 |
EMC3 regulates trafficking and pulmonary toxicity of the SFTPCI73T mutation associated with interstitial lung disease
Xiaofang Tang, Wei Wei, Yuqing Sun, Timothy Weaver, Ernesto S. Nakayasu, Geremy Clair, John Snowball, Cheng-Lun Na, Karen S. Apsley, Emily P. Martin, Darrell Kotton, Konstantinos-Dionysios Alysandratos, Jiuzhou Huo, Jeffery Molkentin, William A. Gower, Xinhua Lin, Jeffrey Whitsett |
Journal of Clinical Investigation | 2024 |
Surfactant Protein-C Regulates Alveolar Type 2 Epithelial Cell Lineages via the CD74 Receptor
Jain KG, Liu Y, Zhao R, Muire PJ, Xi NM, Ji HL |
Journal of respiratory biology and translational medicine | 2024 |
Allogeneic Mesenchymal Stromal Cells as a Global Pediatric Prospective Approach in the Treatment of Respiratory Failure Associated with Surfactant Protein C Dysfunction.
Pelizzo G, Avanzini MA, Croce S, Mandelli A, Lenta E, Farolfi A, Valsecchi C, Zirpoli S, Lanfranchi G, Durante E, Zoia E, Zuccotti G, Calcaterra V |
2023 | |
Effect of Epithelial-Specific MyD88 Signaling Pathway on Airway Inflammatory Response to Organic Dust Exposure
Johnson AN, Dickinson J, Nelson A, Gaurav R, Kudrna K, Evans SE, Janike K, Wyatt TA, Poole JA |
Journal of Immunotoxicology | 2023 |
Cryptotanshinone is a candidate therapeutic agent for interstitial lung disease associated with a BRICHOS-domain mutation of SFTPC
Hosokawa M, Mikawa R, Hagiwara A, Okuno Y, Awaya T, Yamamoto Y, Takahashi S, Yamaki H, Osawa M, Setoguchi Y, Saito MK, Abe S, Hirai T, Gotoh S, Hagiwara M |
iScience | 2023 |
Interstitial Lung Disease in Adulthood Associated with Surfactant Protein C Gene Mutation in a Patient with a History of Lipoid Pneumonia in Infancy
Furukawa T, Akaike K, Iyama S, Masunaga A, Tomita Y, Saeki S, Ichiyasu H, Sakagami T |
Internal Medicine | 2023 |
Insights into the Pathogenesis of Pulmonary Fibrosis from Genetic Diseases
Wang JY, Young LR |
American journal of respiratory cell and molecular biology | 2022 |
Gene Therapeutics for Surfactant Dysfunction Disorders: Targeting the Alveolar Type 2 Epithelial Cell.
Sitaraman S, Alysandratos KD, Wambach JA, Limberis MP |
Human Gene Therapy | 2022 |
Disruption of proteostasis causes IRE1 mediated reprogramming of alveolar epithelial cells.
Katzen J, Rodriguez L, Tomer Y, Babu A, Zhao M, Murthy A, Carson P, Barrett M, Basil MC, Carl J, Leach JP, Morley M, McGraw MD, Mulugeta S, Pelura T, Rosen G, Morrisey EE, Beers MF |
Proceedings of the National Academy of Sciences | 2022 |
Preclinical MRI to quantify pulmonary disease severity and trajectories in poorly characterized mouse models: A pedagogical example using data from novel transgenic models of lung fibrosis
IR Stecker, MS Freeman, S Sitaraman, CS Hall, PJ Niedbalski, AJ Hendricks, EP Martin, TE Weaver, ZI Cleveland |
2021 |